You can buy or sell TTPH and other stocks, options, ETFs, and crypto commission-free!
Tetraphase Pharmaceuticals, Inc. Common Stock, also called Tetraphase Pharmaceuticals, is engaged in the development and production of novel antibiotics for serious and life-threatening bacterial infections. Read More It is currently developing a product candidate, eravacycline, a fully synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.
52 Week High
52 Week Low
-$6.70 per share
-$6.00 per share